Safety, Tolerability, Pharmacokinetics of hzVSf-v13 in Healthy Adults (Intravenous and Subcutaneous Administration)
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Healthy Volunteers
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Sequential AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 60 years
- Gender
- Both males and females
Description
A phase I, double-blind, placebo-controlled, single and multiple dose
A phase I, double-blind, placebo-controlled, single and multiple dose
Tracking Information
- NCT #
- NCT04817202
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: +61-8-70887900 Wabnitz, phD CMAX Clinical Research Pty Ltd
Get Well Soon